Natoli installed a NP-RD30 rotary tablet press for R&D at its new lab in Germany.
Natoli Engineering installed its Natoli NP-RD30 rotary tablet press in its new research and training facility, the Diosna ProcessLab in Osnabrück, Germany. The lab was completed in April 2020 and is built for research and formulation trials as well as virtual and in-person training classes. With the tablet press, the lab offers complete production of tablets from powder mixing, granulation, final blending, and tableting to coating.
The tablet press combines the design of a full-scale production press with the analytical capabilities of an R&D machine. Designed to tackle formulation and scale-up challenges, the tablet press comes equipped with a 21” HMI touchscreen, a USB port for data transfer, rolling casters, a dual vacuum system, a built-in calibration tool, upper and lower punch seals, powder recirculation system, and a self-adjusting lower punch with a push button feature, a Sept. 9, 2020 company press release said. The fast-fill cam design produces a vacuum to help with die filling for tablet weights while featuring diameter pre- and main compression rollers, independent overload, ejection, and take-off force monitoring.
Source: Natoli
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Shilpa Medicare Launches ‘Hybrid CDMO’ at DCAT Week 2025
March 17th 2025This model is being positioned by Shilpa as a dual approach that offers comprehensive discovery, clinical, and commercial outsourcing services in addition to commercially ready, “off-the-shelf” novel formulations for b2b licensing.
Benuvia Granted GMP Certification by Brazil National Health Surveillance Agency
March 14th 2025The certification allows Benuvia to produce pharmaceutical products for companies, either local to Brazil or international, that may be looking for compliant and high-quality production capabilities in the Brazilian pharmaceutical market.